Syncona

Overview

Syncona is a London-based, publicly traded healthcare investment firm focused on founding, building, and scaling global life science companies to deliver transformational treatments for patients in areas of high unmet need.

Year Founded

2012

Portfolio Companies

Website

synconaltd.com

Investments

Syncona investments
Company	Date	Stage	Lead
OMass Therapeutics	Oct 2026	Series C	Co-investor
Re-Aim Therapeutics	May 2026	Seed	Lead
ALTx Therapeutics	Feb 2026	Accelerator	Co-investor
Beacon Therapeutics	Jan 2026	Series C	Co-investor
Apini Therapeutics	Jun 2025	Seed	Co-investor

View all investments

Key People

Elisa Petris

Managing Partner

Roel Bulthuis

Managing Partner

Ben Woolven

Business Strategy And Operations Partner

Hitesh Thakrar

Partner

Gonzalo Garcia

Principal

Alex Hamilton

Investor

Michael Kyriakides

Life Sciences Company Builder And Investor

Usman Sherani

Investor Relations Corporate Communications And Sustainability Associate

View all key people

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium

SeedSeries ASeries BGrowth

Unlock portfolio analytics

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium

2021

2022

2023

2024

2025

2026

Unlock portfolio analytics

FAQ

Firmographic Details

HeadquartersLondon

Year Founded2012

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?